Suppr超能文献

0.02%葡萄糖酸洗必泰作为角膜细菌性溃疡初始治疗的辅助用药。

Chlorhexidine gluconate 0.02% as adjunct to primary treatment for corneal bacterial ulcers.

作者信息

Geffen Noa, Norman Galia, Kheradiya Nisha S, Assia Ehud I

机构信息

Department of Ophthalmology, Meir Medical Center, Kfar Saba, Israel.

出版信息

Isr Med Assoc J. 2009 Nov;11(11):664-8.

Abstract

BACKGROUND

It is common practice to use topical antiseptic formulations prior to specific therapy in superficial infections and injuries, but not in corneal bacterial ulcers. There is accumulating evidence proving chlorhexidine gluconate 0.02%, an antiseptic agent, as an effective treatment for infectious keratitis.

OBJECTIVES

To investigate the safety and efficacy of chlorhexidine gluconate 0.02% as an adjunct therapy for corneal bacterial ulcers.

METHODS

Twenty-six patients with corneal bacterial ulcers were treated with standard empirical antibiotic treatment. The study group was treated with chlorhexidine gluconate 0.02% while controls received placebo for one week. The patients were followed for at least 1 month.

RESULTS

No allergic or toxic reactions were noted. Although a higher baseline severity of ulcers existed in the study group, no differences were found in final vision, scarring extent, or recovery duration.

CONCLUSIONS

Chlorhexidine gluconate 0.02% may improve the clinical course of corneal ulcers.

摘要

背景

在浅表感染和损伤的特定治疗前使用局部抗菌制剂是常见做法,但在角膜细菌性溃疡治疗中并非如此。越来越多的证据表明,0.02%葡萄糖酸氯己定这种抗菌剂可有效治疗感染性角膜炎。

目的

研究0.02%葡萄糖酸氯己定作为角膜细菌性溃疡辅助治疗的安全性和有效性。

方法

26例角膜细菌性溃疡患者接受标准经验性抗生素治疗。研究组使用0.02%葡萄糖酸氯己定治疗,对照组接受安慰剂治疗,为期1周。对患者进行至少1个月的随访。

结果

未观察到过敏或毒性反应。尽管研究组溃疡的基线严重程度较高,但在最终视力、瘢痕形成程度或恢复持续时间方面未发现差异。

结论

0.02%葡萄糖酸氯己定可能改善角膜溃疡的临床病程。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验